메뉴 건너뛰기




Volumn 54, Issue 11, 2015, Pages 2076-2084

The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs

Author keywords

multimorbidity; rheumatoid arthritis; treatment response

Indexed keywords

C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

EID: 84946743703     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kev239     Document Type: Article
Times cited : (69)

References (22)
  • 3
    • 84871156162 scopus 로고    scopus 로고
    • A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome
    • Norton S, Koduri G, Nikiphorou E et al. A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology 2012;52:99-110.
    • (2012) Rheumatology , vol.52 , pp. 99-110
    • Norton, S.1    Koduri, G.2    Nikiphorou, E.3
  • 4
    • 84898597459 scopus 로고    scopus 로고
    • Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity
    • Radner H, Yoshida K, Smolen JS, Solomon DH. Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity. Nat Rev Rheumatol 2014;10:252-6.
    • (2014) Nat Rev Rheumatol , vol.10 , pp. 252-256
    • Radner, H.1    Yoshida, K.2    Smolen, J.S.3    Solomon, D.H.4
  • 5
    • 40049089668 scopus 로고    scopus 로고
    • Polypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidity
    • Treharne GJ, Douglas KM, Iwaszko J et al. Polypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidity. Musculoskeletal Care 2007;5:175-90.
    • (2007) Musculoskeletal Care , vol.5 , pp. 175-190
    • Treharne, G.J.1    Douglas, K.M.2    Iwaszko, J.3
  • 6
    • 84866108933 scopus 로고    scopus 로고
    • Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitions
    • Studenic P, Smolen JS, Aletaha D. Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitions. Ann Rheum Dis 2012;71:1702-5.
    • (2012) Ann Rheum Dis , vol.71 , pp. 1702-1705
    • Studenic, P.1    Smolen, J.S.2    Aletaha, D.3
  • 7
    • 77950307115 scopus 로고    scopus 로고
    • Treating rheumatoid arthritis to target: recommendations of an international task force
    • Smolen JS, Aletaha D, Bijlsma JW et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
    • (2010) Ann Rheum Dis , vol.69 , pp. 631-637
    • Smolen, J.S.1    Aletaha, D.2    Bijlsma, J.W.3
  • 8
    • 84875993860 scopus 로고    scopus 로고
    • Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis
    • Cui J, Stahl EA, Saevarsdottir S et al. Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis. PLoS Genet 2013;9:e1003394.
    • (2013) PLoS Genet , vol.9
    • Cui, J.1    Stahl, E.A.2    Saevarsdottir, S.3
  • 9
    • 84888793924 scopus 로고    scopus 로고
    • Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis
    • Ranganath VK, Maranian P, Elashoff DA et al. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis. Rheumatology 2013;52:1809-17.
    • (2013) Rheumatology , vol.52 , pp. 1809-1817
    • Ranganath, V.K.1    Maranian, P.2    Elashoff, D.A.3
  • 10
    • 79951703895 scopus 로고    scopus 로고
    • Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study
    • Iannaccone CK, Lee YC, Cui J et al. Using genetic and clinical data to understand response to disease-modifying anti-rheumatic drug therapy: data from the Brigham and Women's Hospital Rheumatoid Arthritis Sequential Study. Rheumatology 2010;50:40-6.
    • (2010) Rheumatology , vol.50 , pp. 40-46
    • Iannaccone, C.K.1    Lee, Y.C.2    Cui, J.3
  • 13
    • 23944478301 scopus 로고    scopus 로고
    • Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
    • Aletaha D, Nell VP, Stamm T et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 2005;7:R796-806.
    • (2005) Arthritis Res Ther , vol.7 , pp. R796-806
    • Aletaha, D.1    Nell, V.P.2    Stamm, T.3
  • 14
    • 0028815803 scopus 로고
    • Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
    • Prevoo ML, van 't Hof MA, Kuper HH et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
    • (1995) Arthritis Rheum , vol.38 , pp. 44-48
    • Prevoo, M.L.1    van 't Hof, M.A.2    Kuper, H.H.3
  • 15
    • 77950307115 scopus 로고    scopus 로고
    • Treating rheumatoid arthritis to target: recommendations of an international task force
    • Smolen JS, Aletaha D, Bijlsma JW et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
    • (2010) Ann Rheum Dis , vol.69 , pp. 631-637
    • Smolen, J.S.1    Aletaha, D.2    Bijlsma, J.W.3
  • 16
    • 0034538152 scopus 로고    scopus 로고
    • A reappraisal of HAQ disability in rheumatoid arthritis
    • Wolfe F. A reappraisal of HAQ disability in rheumatoid arthritis. Arthritis Rheum 2000;43:2751-61.
    • (2000) Arthritis Rheum , vol.43 , pp. 2751-2761
    • Wolfe, F.1
  • 17
    • 0026588953 scopus 로고
    • Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables
    • Callahan LF, Bloch DA, Pincus T. Identification of work disability in rheumatoid arthritis: physical, radiographic and laboratory variables do not add explanatory power to demographic and functional variables. J Clin Epidemiol 1992;45:127-38.
    • (1992) J Clin Epidemiol , vol.45 , pp. 127-138
    • Callahan, L.F.1    Bloch, D.A.2    Pincus, T.3
  • 18
    • 0023774938 scopus 로고
    • The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis
    • Wolfe F, Kleinheksel SM, Cathey MA et al. The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis. J Rheumatol 1988;15:1480-8.
    • (1988) J Rheumatol , vol.15 , pp. 1480-1488
    • Wolfe, F.1    Kleinheksel, S.M.2    Cathey, M.A.3
  • 19
    • 77949450905 scopus 로고    scopus 로고
    • Impact of comorbidity on physical function in patients with rheumatoid arthritis
    • Radner H, Smolen JS, Aletaha D. Impact of comorbidity on physical function in patients with rheumatoid arthritis. Ann Rheum Dis 2009;69:536-41.
    • (2009) Ann Rheum Dis , vol.69 , pp. 536-541
    • Radner, H.1    Smolen, J.S.2    Aletaha, D.3
  • 20
    • 78751695495 scopus 로고    scopus 로고
    • Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis
    • Radner H, Smolen JS, Aletaha D. Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology 2010;50:381-8.
    • (2010) Rheumatology , vol.50 , pp. 381-388
    • Radner, H.1    Smolen, J.S.2    Aletaha, D.3
  • 21
    • 34547939157 scopus 로고    scopus 로고
    • Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study
    • Mancarella L, Bobbio-Pallavicini F, Ceccarelli F et al. Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol 2007;34:1670-3.
    • (2007) J Rheumatol , vol.34 , pp. 1670-1673
    • Mancarella, L.1    Bobbio-Pallavicini, F.2    Ceccarelli, F.3
  • 22
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
    • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
    • (1987) J Chronic Dis , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3    MacKenzie, C.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.